Taika Capital LP Acquires Shares of 3,798 Encompass Health Co. (NYSE:EHC)

Taika Capital LP acquired a new stake in shares of Encompass Health Co. (NYSE:EHC) during the fourth quarter, Holdings Channel reports. The firm acquired 3,798 shares of the company’s stock, valued at approximately $351,000.

A number of other institutional investors also recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after acquiring an additional 137 shares in the last quarter. Avior Wealth Management LLC acquired a new position in shares of Encompass Health in the 3rd quarter worth approximately $40,000. Tompkins Financial Corp acquired a new position in shares of Encompass Health in the 4th quarter worth approximately $46,000. V Square Quantitative Management LLC boosted its holdings in shares of Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after acquiring an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc acquired a new position in shares of Encompass Health in the 3rd quarter worth approximately $68,000. Institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

EHC stock opened at $99.20 on Monday. The business’s fifty day moving average is $96.95 and its 200-day moving average is $96.80. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The company has a market cap of $9.99 billion, a P/E ratio of 22.24, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a twelve month low of $74.27 and a twelve month high of $104.55.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Equities research analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio is currently 15.25%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on EHC shares. William Blair reissued an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. KeyCorp upped their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Monday, February 10th. StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, February 15th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. Finally, Barclays upped their price objective on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. Ten research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $107.67.

Insider Activity at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. This represents a 6.79 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 2.10% of the stock is owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.